Cefadroxil: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 20: | Line 20: | ||
'''| [[Cefadroxil clinical studies|Clinical Studies]]''' | '''| [[Cefadroxil clinical studies|Clinical Studies]]''' | ||
'''| [[Cefadroxil dosage and administration|Dosage and Administration]]''' | '''| [[Cefadroxil dosage and administration|Dosage and Administration]]''' | ||
'''| [[Cefadroxilhow supplied|How Supplied]]''' | '''| [[Cefadroxilhow supplied|How Supplied]]''' | ||
'''| [[Cefadroxil labels and packages|Labels and Packages]]''' | '''| [[Cefadroxil labels and packages|Labels and Packages]]''' | ||
Revision as of 04:05, 27 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Category
US Brand Names
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages